Skip to product information
1 of 1

Elabscience

SKU:E-AB-68070

Phospho-MDM2(S166) Polyclonal Antibody

Phospho-MDM2(S166) Polyclonal Antibody

Regular price $540.00 USD
Regular price Sale price $540.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Concentration
Host

Phospho-MDM2(S166) Polyclonal Antibody

The PHOSPHO-MDM2(S166) Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of phosphorylated MDM2 at serine 166. MDM2, also known as mouse double minute 2 homolog, is a crucial regulator of the tumor suppressor protein p53. Phosphorylation of MDM2 at serine 166 has been implicated in various cellular processes, including cell cycle regulation, DNA damage response, and apoptosis.

This polyclonal antibody has been meticulously developed and validated to ensure exceptional performance in various applications, such as Western blotting, immunoprecipitation, and immunofluorescence. It exhibits minimal cross-reactivity with non-phosphorylated MDM2 and other related proteins, ensuring accurate and reliable results.

The PHOSPHO-MDM2(S166) Polyclonal Antibody demonstrates high affinity and specificity towards phosphorylated MDM2 at serine 166, enabling precise detection and quantification of this critical post-translational modification. Its exceptional sensitivity allows for the detection of low levels of phosphorylated MDM2, making it an ideal tool for both basic research and clinical applications.

This antibody is produced using state-of-the-art techniques, ensuring batch-to-batch consistency and reproducibility. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation. The antibody is provided in a convenient format, allowing for easy storage and handling.

In summary, the PHOSPHO-MDM2(S166) Polyclonal Antibody is a reliable and efficient tool for the detection and analysis of phosphorylated MDM2 at serine 166. Its high specificity, sensitivity, and ease of use make it an invaluable asset for researchers and clinicians studying the intricate mechanisms of MDM2 regulation and its implications in various diseases, including cancer.

View full details